Literature DB >> 31508349

Huge central intravascular papillary endothelial hyperplasia of the mandible: a case report and review of the literature.

Hassan Mirmohammadsadeghi1, Fatemeh Mashhadiabbas2, Fatemeh Latifi1.   

Abstract

Masson's tumor or intravascular papillary endothelial hyperplasia is an inflammatory soft tissue lesion that rarely occurs in the maxillofacial region and skeletal system. Precise clinical and para-clinical investigation is necessary for the accurate diagnosis and correct treatment of this lesion. This paper presents a massive intravascular papillary endothelial hyperplasia lesion in the bony tissue of the mandible. Histopathology features, clinical appearance, and suitable management are discussed, with a complete review of the literature. The patient underwent composite resection of the lesion as well as reconstruction. No recurrence was observed during 6 years of follow-up. To the best of our knowledge, this is the fourth case of Masson's tumor in mandibular skeletal tissue, which has unique and distinctive features due to its size and location. A rare occurrence in skeletal tissue, complex clinical presentations, and complicated histopathologic findings present diagnostic challenges for treatment of this lesion.

Entities:  

Keywords:  Bone; Histopathology; Intravascular papillary endothelial hyperplasia; Mandible

Year:  2019        PMID: 31508349      PMCID: PMC6728626          DOI: 10.5125/jkaoms.2019.45.4.180

Source DB:  PubMed          Journal:  J Korean Assoc Oral Maxillofac Surg        ISSN: 1225-1585


I. Introduction

Intravascular papillary endothelial hyperplasia (IPEH) was first described in 1923 by Masson1 as hemangioendotheliome vegetant intravasculaire. It is a benign vascular lesion that predominantly occurs in the skin and subcutaneous tissue of the trunk, fingers, and head and neck regions. Oral IPEH lesions are uncommon and a review of oral lesions conducted in 2004 reported only 91 cases of the oral mucosa and lips2. IPEH is an inflammatory vascular lesion with a trauma etiology and nonspecific clinical characteristics. Due to the complex presentation, it should be differentiated from other soft tissue tumors, especially angiosarcoma. According to the literature, only three cases of IPEH in the maxillofacial skeletal tissues have been reported previously345.(Table 1) This article describes a case of pure IPEH involving half of the mandible. The lesion mimicked a malignant tumor and because of the uncommon location, huge size, and complicated histology, representing a considerable diagnostic challenge.
Table 1

Reports of intravascular papillary endothelial hyperplasia in maxillofacial skeletal tissue

StudyAge (yr)/sexLocationChief complainClinical appearanceRadiographic finding
Komori et al.3 (1984)49/FRight mandibular body; from the #44 to #47 tooth region-Normal covering mucosaMultilocular radiolucency
Xu and Li4 (2014)14/MRight ramus of mandible; 5×5×6 cm involved buccal space and extended into infratemporal fossaFacial swelling and trismusFirm, painful, fixed massMultilocular, expansile, well-circumscribed, osteolytic lesion with cortex destruction
Tanio et al.5 (2016)75/MAnterior mandible; from the #32 to #44 tooth regionPain on the left side of the mandibleBony hard swelling, normal mucosa, persistent bleeding at biopsyMultilocular radiolucent lesion with cortical bones destruction
Our case45/MLeft side of mandible; from tooth #32 to the left mandibular ramus with vertical extension to the maxillary vestibule and sub lingual and sub mandibular regionHuge malodorous massEnlarged ulcerative mass with necrotic appearance, easy bleeding, facial asymmetryMassive multilocular osteolytic lesion with bony expansion and cortex destruction

(F: female, M: male)

II. Case Report

A 45-year-old male was referred to the Department of Oral and Maxillofacial Surgery of Taleghani Hospital (Shahid Beheshti University of Medical Sciences, Tehran, Iran) in 2011, with a chief complaint of a huge malodorous mass in the mouth. Five years ago, during dental visit, the patient first noticed a small prominent lesion on the left side of mandible. The patient did not seek treatment and the lesion gradually progressed to a large destructive mass. The mass grew suddenly and considerably in the past two months. Extraoral examination revealed obvious facial asymmetry due to bulging of the left side of face from the buccal to the submandibular region.(Fig. 1) The skin was intact without any sloughing or color change. The patient suffered from paresthesia of the left infraalveolar nerve and severe halitosis. Intraoral examination revealed a huge, expansile lesion from tooth #32 to the left mandibular ramus, which caused tooth displacement. Vertical extension to the maxillary vestibule and sublingual region was evident. The bulky lesion displaced the tongue and interfered with mouth movement. The lesion was covered by ulcerative and necrotic tissue.(Fig. 2) The patient reported easy bleeding of the lesion, which was spontaneous or caused by minor trauma. Due to its dark appearance, the first clinical diagnosis by the Department of Oral Medicine was melanoma. Panoramic radiography and computed tomography revealed an extended multilocular osteolytic lesion with bony expansion and cortical destruction. There was obvious tooth displacement and root resorption.(Fig. 3, 4)
Fig. 1

Extraoral appearance of the lesion.

Fig. 2

Intraoral appearance of the lesion.

Fig. 3

Extraoral radiography of the lesion. A. Panoramic view. B. Posteroanterior mandible view.

Fig. 4

Computed tomography of the lesion. A. Three-dimensional view. B. Axial view.

Based on the clinical and radiographic examinations, the differential diagnosis focused on malignant bony tumors including intraosseous odontogenic carcinoma, clear cell odontogenic carcinoma, ameloblastic fibrosarcoma, and osteosarcoma. Incisional biopsy was performed and histologic sections showed a necrotic lesion with mixed inflammatory cells and fungal hyphae, likely Mucorales. Because pathology confirmed a diagnosis of mucormycosis, the patient underwent left hemimandibulectomy with bone and soft tissue resection (Fig. 5) and reconstruction with a reconstruction plate and a pectoralis major myocutaneous pedicled flap. Definitive histopathologic examination of the resected specimen confirmed a vascular tumor characterized by numerous papillae formation in the vessels. The papillae were covered by one to two layers of endothelial cells and encompassed a hyalinized fibrous tissue core. The vascular lumen was dilated with thrombosis and many hemorrhages. (Fig. 6) Surgical margins showed inflamed granulation tissue with cholesterol clefts and reactive bone formation. The intraoral part of the tumor was covered by an ulcerated epithelium with a fibrinopurulent membrane in some areas. There was no evidence of malignancy. The lesion was finally diagnosed as pure-type IPEH. The postoperative course was uneventful and there was no recurrence during seven years of follow-up.
Fig. 5

Resected specimen.

Fig. 6

Histologic section (H&E staining). A. Papillary endothelial cell proliferation in the dilated vascular lumen (×40). B. Papillae lined by plump endothelial cells (×100). C. Papillae with a vascular core lined by active endothelial cells (×200).

III. Discussion

IPEH is a rare vascular lesion of the skin and subcutaneous tissue and can be distinguished by multiple papillary processes and proliferation of endothelial cells6. Masson first described this lesion as a form of endothelial cell neoplasm causing subsequent vascular obstruction and tissue necrosis7. Other investigators focused on the reactive process of the lesion following thrombus organization and endothelization8. Hyperemia or lymph stasis and local production of angiogenic growth factors are another suggested pathogenesis of this lesion. Expression of Ki-67 during active phases of the cell cycle suggest a neoplastic source of the lesion9, but due to granulation tissue formation, a reactive etiology of endothelial cell proliferation is the most likely pathogenesis of IPEH10. Most prior studies cited hormonal impacts and the female predilection of the lesion11. IPEH is more common in older patients and the most common regions are the head and neck (23%), lower extremities (17%), and fingers (16%)12. It rarely occurs in the oral cavity and most intraoral sites are the lower lip followed by the tongue, buccal mucosa, and upper lip13. In 1983, Hashimoto et al.14 described three subtypes of IPEH: (1) pure, developing in the dilated vessels of the figure and head-neck region; (2) mixed, forming over a preexisting lesion like a hemangioma, artero-vascular malformation, pyogenic granulomatosis, aneurysm, or chronic disease with venous thrombosis; or (3) extravascular, originating from previous hematoma with a history of trauma. Similar to the common occurrence of phleboliths in vascular lesions, numerous microcalcifications may be seen in IPEH that cause vascular occlusion and tissue necrosis. Because of the diverse presentations of this lesion, computed tomography with contrast media or magnetic resonance imaging reveals the vascularity and extent of lesion, but have limited usefulness in differential diagnosis15. Clinical manifestations of the lesion are not specific and it is difficult to differentiate from other neoplasms or vascular lesions. Thus, according to location and size, IPEH may mimic different lesions such as mucoceles, hemangiomas, hematomas, intravenous pyogenic granulomas, phlebectasias, salivary gland tumors, nevi, Kaposi's sarcomas, or angiosarcomas. Angiosarcoma is the most important malignant lesion to differentiate from IPEH. Areas of organized thrombus in the dilated vessels and proliferation of endothelial cells in papillary form toward the lumen are important for diagnosis of IPEH. The circumscribed and intravascular location of the lesion and presence of thrombotic material, along with absence of nuclear hyperchromia, cellular pleomorphism, atypical mitosis, foci of necrosis, and irregular capillary vessels are also major features differentiating IPEH from angiosarcoma16. Complete excision with healthy margins is the accepted treatment plan. Cohen et al.17 used sclerotherapy with sodium tetradecyl sulfate prior to resection with the aim of minimizing bleeding and improving esthetic results in one case of mixed IPEH of lip. Other treatment methods like endoscopic surgery and use of beta-adrenergic antagonists were reported according to the site involved18. In the case of multiple intracranial lesions or anatomic limitations that could result in incomplete resection, adjuvant radiotherapy or chemotherapy have been associated with a good prognosis19. Although recurrence of the IPEH is rare, incomplete resection or recurrence of the primary vascular lesion are possible causes. Furthermore, in the case of recurrent IPEH, thorough investigation to rule out angiosarcoma is needed. The case reported here is notable because of some particularities: First it is the fourth reported case of IPEH in the mandible. Since the first mandibular lesion was reported in 19843, Xu and Li4 reported one case of IPEH at the mandibular ramus with expansile and osteolytic characteristics in 2014. The lesion appeared with swelling and trismus and was initially thought to be a case of fibrous dysplasia, ameloblastoma, and giant cell tumor. In 2016, Tanio et al.5 reported a mixed IPEH associated with hemangioma of the anterior segment of the mandible, in which embolization of the inferior alveolar artery was performed followed by successful removal. None of the reported lesions were as large or as long-term as this case, with significant intraoral and extraoral extension. The large size of this lesion and subsequent local circulation disorder resulted in tissue necrosis and fungal infection, leading to the diagnostic challenge and variation in pathologic results encountered in this case. According to the literature, not only are mandibular IPEH lesions rare, but the occurrence of IPEH in skeletal tissue is also uncommon13. Jain et al.20 reported one case of IPEH in the hard palate masquerading as adenoid cystic carcinoma. Resection of multiple recurrent IPEHs affecting the skin and tibia in a 75-year-old male over the course of three years was reported by Higashi et al.21 in 2009. The patient had hepatitis C, hepatoma, and associated coagulopathy and it was suggested that liver dysfunction and induced microthrombus formation were the probable etiology. The spine, skull, and skull base are other skeletal sites involved in IPEH that have been reported in the literature22232425. In conclusion, IPEH as an inflammatory vascular soft tissue lesion may occur in hard tissue of the head and neck region, without a history of trauma. Tissue necrosis and mixed infection are the result of circulation disruption. Differentiating this lesion from malignant vascular tumors like angiosarcoma is an important and challenging task for oral and maxillofacial pathologists and surgeons.
  21 in total

Review 1.  Intracranial Masson tumor: case report and literature review.

Authors:  Chie-Schin Shih; Richard Burgett; Jose Bonnin; Joel Boaz; Chang Yueh Ho
Journal:  J Neurooncol       Date:  2012-01-26       Impact factor: 4.130

2.  Periocular papillary endothelial hyperplasia (Masson's tumour) in Behçet's disease.

Authors:  David T L Liu; Carol L Shields; Gary M K Tse; Dennis S C Lam
Journal:  Acta Ophthalmol       Date:  2011-10-19       Impact factor: 3.761

3.  Intravascular papillary endothelial hyperplasia manifesting as a submandibular mass: an unusual presentation in an uncommon location.

Authors:  Don Kim; Howard Israel; Mark Friedman; William Kuhel; Claude-Jean Langevin; Tara Plansky
Journal:  J Oral Maxillofac Surg       Date:  2007-04       Impact factor: 1.895

Review 4.  Multifocal intravascular papillary endothelial hyperplasia in the retroperitoneum and spine: a case report and review of the literature.

Authors:  Max Petry; Michele A Brown; John R Hesselink; Steven G Imbesi
Journal:  J Magn Reson Imaging       Date:  2009-04       Impact factor: 4.813

5.  Intravascular papillary endothelial hyperplasia of the palate masquerading as adenoid cystic carcinoma on fine needle aspiration cytology: a potential diagnostic pitfall.

Authors:  S Jain; N Khurana; A Gulati
Journal:  Cytopathology       Date:  2011-03-08       Impact factor: 2.073

6.  Intravascular papillary endothelial hyperplasia (Masson's hemangioma) presenting as a soft-tissue sarcoma.

Authors:  Dimitris P Korkolis; Maria Papaevangelou; George Koulaxouzidis; Nikos Zirganos; Helen Psichogiou; Perikles P Vassilopoulos
Journal:  Anticancer Res       Date:  2005 Mar-Apr       Impact factor: 2.480

7.  Multiple intravascular papillary endothelial hyperplasia affecting skin and bone.

Authors:  Y Higashi; Y Uchida; N Yoshii; H Kubo; T Kanzaki; M Yokouchi; T Kanekura
Journal:  Clin Exp Dermatol       Date:  2009-07-29       Impact factor: 3.470

Review 8.  Sinonasal intravascular papillary endothelial hyperplasia successfully treated by endoscopic excision: a case report and review of the literature.

Authors:  Zhen-Hong Wang; Chung-Han Hsin; Shiou-Yi Chen; Cheng-Yu Lo; Po-Wen Cheng
Journal:  Auris Nasus Larynx       Date:  2008-09-09       Impact factor: 1.863

Review 9.  Intravascular papillary endothelial hyperplasia of the lower lip: surgical approach and review of the literature.

Authors:  A Cohen; A Maly; B Azaz
Journal:  Gerodontology       Date:  2009-08-21       Impact factor: 2.980

10.  Intravascular Papillary Endothelial Hyperplasia (Masson's Tumor) of the Mouth - A Case Report.

Authors:  Ronell Bologna-Molina; Guillermo Amezcua-Rosas; Israel Guardado-Luevanos; Patricia Lorelei Mendoza-Roaf; Tomás González-Montemayor; Nelly Molina-Frechero
Journal:  Case Rep Dermatol       Date:  2010-02-06
View more
  2 in total

1.  An Uncommon Great Pretender in Oral Cavity Lesions: The Masson's Tumor.

Authors:  Dafne Gascón; Andrés Rivera; Marc Agea; Raúl Antúnez-Conde; Ángela Sada; Carlos Navarro-Cuéllar; Manuel Tousidonis-Rial; Jose Ignacio Salmerón-Escobar
Journal:  Head Neck Pathol       Date:  2022-03-07

2.  Intravascular papillary endothelial hyperplasia in the mandible: a case report.

Authors:  Takanori Eguchi; Kazutoshi Nakaoka; Akihiko Basugi; Go Arai; Yoshiki Hamada
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.